Original ArticleExtracardiac findings with increased perfusion during clinical O-15-H2O PET/CT myocardial perfusion imaging: A case series
Section snippets
Background
Ischemic heart disease is the leading cause of death worldwide, and hence, diagnosis and guidance of medical treatment and interventional revascularization are of great importance. In nuclear medicine, regional myocardial ischemia can be assessed by single-photon emission computed tomography (SPECT) or positron emission tomography (PET) with comparison of a rest and a stress scan (exercise or pharmacologically induced). Recently, myocardial perfusion flow imaging (MPI) using PET has proven
Methods
O-15-H2O PET MPI was implemented in daily clinical routine in May 2020. All scans were interpreted as routine clinical reads by a nuclear medicine specialist, and in most cases also by a resident doctor. Cases were collected consecutively during daily clinical work, especially since June 2021. Additionally, the reports of all scans were retrospectively reviewed, assessing the rate of coincidental findings.
All patients were scanned according to the standard clinical MPI protocol for O-15-H2O at
Results
In total, 2963 patients have undergone clinical O-15-H2O PET MPI at our department. 371 (13%) of these included reports of coincidental findings, generally findings on low-dose CT. 135 (36%) of the coincidental findings were unchanged lung nodules and 142 (38%) were various benign conditions. Benign lung conditions constitute the majority of benign findings, such as atelectasis, pleural effusion, pneumonia, pleural plaques, bullae, etc., but also cysts, fractures, hernia and benign mamma
Discussion
The present case series demonstrates various malignant and benign coincidental findings with increased perfusion, detected during clinical O-15-H2O PET MPI. PET imaging of tumour perfusion has been proposed as a potential cancer biomarker10 and has been studied with O-15-H2O PET in various malignancies including brain,11,12 head and neck,13,14 lung,15 breast,16,17 pancreas,18 cervix uteri,19 abdominal,20 and prostate cancer.21,22 Furthermore, increased perfusion has been described in studies
New knowledge gained
Benign and malignant coincidental extracardiac findings with increased perfusion are frequently encountered on O-15-H2O PET/CT. These coincidental findings and a discussion of indirect measures of adenosine response has not previously been described using O-15-H2O, but fits in line with the clinical experience from perfusion imaging with other PET tracers. The paper provides clinically relevant information for colleagues at PET-centers who perform cardiac PET, and especially those who consider
Conclusions
Both malignant and benign extracardiac coincidental findings with increased perfusion are readily visible and frequently encountered on summed O-15-H2O PET images. In most cases, the coincidental findings can be verified by lesions on the accompanying low-dose CT-scan. We therefore recommend evaluating summed O-15-H2O images in addition to the cardiac software’s display of parametric MBF images when doing an O-15-H2O MPI report.
Acknowledgements
Mads R Jochumsen was financially supported by NEYE-Fonden, Louis-Hansen Fonden and Fabrikant Einar Willumsens Mindelegat. Lars C Gormsen has an unrestricted grant from the Novo Nordisk Foundation (NNF19OC0055100).
Author contributions
All authors contributed with patient cases and/or technical and academic guidance. The manuscript was drafted by MRJ and TØB. All authors read, critically revised, and approved the final manuscript.
Disclosures
The authors MRJ, DLO, MHV, MAM, LPT, LCG and TØB declare that they have no disclosures.
Funding
References (45)
- et al.
PET and SPECT tracers for myocardial perfusion imaging
Semin Nucl Med
(2020) - et al.
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?
J Nucl Cardiol
(2012) - et al.
15O-water PET MPI: Current status and future perspectives
Semin Nucl Med
(2020) - et al.
Incidental extra-cardiac findings on (13)N-ammonia myocardial perfusion PET/CT
J Nucl Cardiol
(2017) - et al.
PET imaging of tumor perfusion: A potential cancer biomarker?
Semin Nucl Med
(2020) - et al.
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer
Int J Radiat Oncol Biol Phys
(2004) - et al.
Alteration of blood-brain barrier in human brain tumors: Comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET
J Neurol Sci
(1995) - et al.
Rubidium-82 uptake in metastases from neuroendocrine tumors: No flow response to adenosine
J Nucl Cardiol
(2016) - et al.
Splenic switch-off as a predictor for coronary adenosine response: Validation against 13N-ammonia during co-injection myocardial perfusion imaging on a hybrid PET/CMR scanner
J Cardiovasc Magn Reson
(2021) - et al.
Cardiac metastasis from lung cancer mimicking as perfusion defect on N-13 ammonia and FDG myocardial viability PET/CT scan
J Nucl Cardiol
(2017)
Incremental diagnostic value of regional myocardial blood flow quantification over relative perfusion imaging with generator-produced rubidium-82 PET
Circ J
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve
Circulation
Quantification of myocardial blood flow with 82Rb dynamic PET imaging
Eur J Nucl Med Mol Imaging
Extracardiac abnormalities on rubidium-82 cardiac positron emission tomography/computed tomography
Nucl Med Commun
Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner
Eur J Nucl Med Mol Imaging
Brain perfusion CT compared with 15O-H2O PET in patients with primary brain tumours
Eur J Nucl Med Mol Imaging
Spatial heterogeneity of low-grade gliomas at the capillary level: A PET study on tumor blood flow and amino acid uptake
J Nucl Med
Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy
Eur J Nucl Med Mol Imaging
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography
Clin Cancer Res
Blood flow and metabolism in locally advanced breast cancer: Relationship to response to therapy
J Nucl Med
Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: A H2(15)O PET and 18F-FDG PET study
Nucl Med Commun
Decreased blood flow with increased metabolic activity: A novel sign of pancreatic tumor aggressiveness
Clin Cancer Res
Cited by (3)
Prevalence and nature of extracardiac findings in PET/CT myocardial perfusion imaging
2023, Journal of Nuclear CardiologyQuantitative Perfusion Imaging with Total-Body PET
2023, Journal of Nuclear Medicine
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarises the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
The authors have also provided an audio summary of the article, which is available to download as ESM, or to listen to via the JNC/ASNC Podcast.
All editorial decisions for this article, including selection of reviewers and the final decision, were made by guest editor Saurabh Malhotra, MD, MPH.
Copyright comment Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.